# Clinical Study on the Mass Balance of Clifutinib

> **NCT07211165** · PHASE1 · COMPLETED · sponsor: **Sunshine Lake Pharma Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Adult Male

## Interventions

- **DRUG:** [14C]Clifutinib

## Key facts

- **NCT ID:** NCT07211165
- **Lead sponsor:** Sunshine Lake Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-29
- **Primary completion:** 2025-11-05
- **Final completion:** 2025-11-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211165, "Clinical Study on the Mass Balance of Clifutinib". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07211165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*